Comparison of High- and Low-Dose Rivaroxaban Regimens in Elderly East Asian Patients With Atrial Fibrillation

CONCLUSION: This study revealed the safety and effectiveness of either dose regimen of rivaroxaban in an Asian population for stroke prevention of AF. Considerable numbers of patients are receiving LDRR therapy in real-world practice in Asia. Both regimens were safe and effective for these patients.TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04096547.PMID:38442717 | PMC:PMC10911935 | DOI:10.3346/jkms.2024.39.e72

Source: Journal of Korean Medical Science - March 5, 2024 Category: Biomedical Science Authors: Ju Youn Kim Juwon Kim Seung-Jung Park Kyoung-Min Park June Soo Kim Sung-Hwan Kim Jaemin Shim Eue Keun Choi Dae-Hyeok Kim Il-Young Oh Young Keun On XAIENT Study Group Source Type: research